Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden

Scandinavian Journal of Infectious Diseases
Annika BergmanUlf Persson

Abstract

The 7-valent pneumococcal conjugate vaccine (PCV-7) has proved to be highly effective against invasive pneumococcal disease and has also provided some protection against all-cause pneumonia and acute otitis media. The objective of this study was to evaluate the projected health benefits, costs and cost-effectiveness of vaccination with the 7-valent conjugated pneumococcal vaccine compared with no vaccination, in all infants in Sweden, taking herd immunity into account. A Markov model was used and a hypothetical birth cohort was simulated for a lifelong perspective. The results show that vaccination of 1 cohort could potentially prevent 9 cases of pneumococcal meningitis, 22 cases of pneumococcal septicaemia, 509 cases of hospitalized pneumonia, 7812 cases of acute otitis media, and 2.7 fatalities, among children 0-4 y of age and 6 episodes of pneumococcal meningitis and 167 cases of pneumococcal septicaemia among adults. The incremental cost per QALY and LY gained was estimated to Euro 29,200 and Euro 51,400, respectively. When herd immunity was accounted for, the cost per QALYand LY gained was estimated to Euro 5500 and Euro 6600, respectively. Thus, the health benefits of a national vaccination programmeme can be achieved wit...Continue Reading

References

Mar 1, 1981·Reviews of Infectious Diseases·J O Klein
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W P HausdorffG R Siber
Oct 13, 2000·Journal of General Internal Medicine·J A BrandenburgM J Fine
Feb 15, 2001·The New England Journal of Medicine·J EskolaUNKNOWN Finnish Otitis Media Study Group
Oct 24, 2001·Scandinavian Journal of Infectious Diseases·M S DahlA Rosengren
Feb 20, 2002·International Journal of Pediatric Otorhinolaryngology·Flemming S VassbotnPer Moller
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
May 7, 2003·The Annals of Otology, Rhinology, and Laryngology·Jacob SadéDavid Cohen
Sep 30, 2003·Scandinavian Journal of Infectious Diseases·Jonas HedlundGöran Kronvall
Nov 5, 2003·International Journal of Pediatric Otorhinolaryngology·M StraetemansT Kilpi
Jul 24, 2004·BMJ : British Medical Journal·Michael D Rawlins, Anthony J Culyer
Nov 26, 2005·Scandinavian Journal of Infectious Diseases·Heini SaloTerhi Kilpi

❮ Previous
Next ❯

Citations

Apr 5, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Yoko IbukaAlison P Galvani
May 6, 2011·Journal of Multidisciplinary Healthcare·Anouk SpeetsCristina Cardoso
Jun 16, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Scott D GrosseDavid Feeny
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Richard PitmanUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Jan 25, 2011·Scandinavian Journal of Public Health·Anouk M SpeetsPatrik A Sobocki
Sep 20, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Richard PitmanUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Nov 30, 2013·PharmacoEconomics·Katelijne van de VoorenLivio Garattini
Jan 22, 2011·PharmacoEconomics·Chantal W B BoonackerMaroeska M Rovers
Apr 11, 2012·Cadernos de saúde pública·Bianca Rezende LucarevschiSandra Grisi
Oct 24, 2018·Applied Health Economics and Health Policy·Tara A LavellePei-Jung Lin
Nov 9, 2017·Human Vaccines & Immunotherapeutics·Xu-Hao ZhangChul-Min Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Scandinavian Journal of Infectious Diseases
Heini SaloTerhi Kilpi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Chiaojung Jillian TsaiCarlos G Grijalva
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Lesley TilsonMichael Barry
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Karen M MiernykAlan J Parkinson
© 2022 Meta ULC. All rights reserved